Liposomal Doxorubicin and Trastuzumab in Treating Women With Advanced Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: BIOLOGICAL: trastuzumab|DRUG: pegylated liposomal doxorubicin hydrochloride
Sponsor: NYU Langone Health
Collaborators: National Cancer Institute (NCI)